AJOVY Subcutaneous Injection Long-term Specified Use-results Survey
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
To evaluate the long-term safety of AJOVY in patients under actual use conditions and to specifically evaluate cardiovascular events. In addition, information on efficacy will be collected.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• \-
Locations
Other Locations
Japan
Pharmacovigilance Department
RECRUITING
Osaka
Contact Information
Primary
Pharmacovigilance Department Otsuka Pharmaceutical Co., Ltd
komaniwa.satoshi@otsuka.jp
+81-6-6943-7722
Time Frame
Start Date: 2022-04-20
Estimated Completion Date: 2029-06-22
Participants
Target number of participants: 1000
Treatments
Drug
Ajovy syringe for SC injection 225 mg.
Related Therapeutic Areas
Sponsors
Leads: Otsuka Pharmaceutical Co., Ltd.